Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features

J Pediatr. 2017 Oct:189:92-97.e1. doi: 10.1016/j.jpeds.2017.05.077. Epub 2017 Jun 26.

Abstract

Objective: To assess the prevalence of overweight/obesity in a cohort of Italian children with Down syndrome (DS) and to investigate the correlation of both obesity and DS with nonalcoholic fatty liver disease (NAFLD).

Study design: We enrolled 280 children with DS (age range 5-18 years), who were referred to the DS outpatient clinic of the Bambino Gesù Children's Hospital in Rome. For all children, we collected the clinical history and measured anthropometric variables. Eighty-four of 280 children with DS were selected to undergo liver ultrasound scanning to evaluate the presence of NAFLD.

Results: Italian children with DS exhibited a prevalence of 19.64% for overweight and 12.14% for obesity. The prevalence of NAFLD in nonobese (45%) and overweight/obese (82%) children with DS is greater than in the European pediatric nonobese (5.7%) or obese population (33%). Moreover, the severity of liver brightness on ultrasound scan correlated positively with body mass index, triglycerides, low-density lipoprotein-cholesterol, and leptin levels and negatively with adiponectin.

Conclusions: We demonstrated that, independently from the obese phenotype, children with DS display a greater risk to develop NAFLD than the general pediatric population.

Keywords: Down syndrome; NAFLD; adipocytokines; children; obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adolescent
  • Anthropometry
  • Child
  • Child, Preschool
  • Down Syndrome / complications*
  • Female
  • Humans
  • Italy / epidemiology
  • Lipids / blood
  • Liver / pathology
  • Male
  • Non-alcoholic Fatty Liver Disease / complications
  • Non-alcoholic Fatty Liver Disease / epidemiology*
  • Overweight / complications
  • Overweight / epidemiology*
  • Pediatric Obesity / complications
  • Pediatric Obesity / epidemiology*
  • Prevalence
  • Risk Factors

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Lipids